From October 1, 2022 to December 31, 2022, the company has repurchased 467,332 shares, representing 1.51% for $1.22 million. With this, the company has completed the repurchase of 3,881,658 shares, representing 11.61% for $14.22 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 USD | +4.94% | -1.86% | -20.31% |
13/05 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
09/05 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.31% | 3.28Cr | |
-27.64% | 1.63TCr | |
-40.03% | 296.02Cr | |
+12.98% | 178.89Cr | |
-8.58% | 152.39Cr | |
+31.19% | 132.52Cr | |
-16.01% | 97Cr | |
-27.24% | 83Cr | |
+7.22% | 84Cr | |
-26.15% | 62Cr |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.